MARK ZAUSS - THERAPY
  • Home
  • Credentials
    • Published Articles
  • ADHD
    • Adult ADHD Self-Report Scale
    • ADHD Comprehensive Assessment
    • ADHD Management
    • ADHD Atypical Symptoms
    • ADHD Medications >
      • Adderall
      • Vyvanse
      • Methylphenidate
      • Concerta
      • Focalin (dexmethylphenidate)
      • Guanfacine (Intuniv)
      • Atomoxetine (Strattera)
      • Clonidine (Kapvay)
      • Onyda XR
      • Wellbutrin
      • Qelbree
      • Azstarys
      • Xelstrym
    • ADHD Medication for Anxiety >
      • Sertraline
      • Wellbutrin
      • Escitalopram (Lexapro)
      • Duloxetine (Cymbalta)
      • Venlafaxine (Effexor)
      • Buspirone (Buspar)
      • Fluoxetine (Prozac)
      • Paroxetine (Paxil)
      • Propranolol (Inderal)
      • Accutane - Adverse effects
    • Pomodoro Technique
    • ADHD Neurochemical
    • ADHD Worksheets
  • Anxiety
    • Insomnia
    • Sertraline
    • Buspirone (Buspar)
    • Fluoxetine (Prozac)
    • Effexor
    • Paroxetine (Paxil)
    • Escitalopram (Lexapro)
  • AUD
    • AUD Medications >
      • Naltrexone
      • Acamprosate
      • Disulfiram (Antabuse)
      • Topamax
      • Gabapentin
    • What to expect
    • Nutrition
    • Resources
    • Overcoming Shame
    • Health and Alcohol
    • AUD Videos
  • Bipolar
    • Bipolar Disorder Treament
    • Bipolar Disorder Worksheets
    • Bipolar Disorder Medications >
      • Abilify
      • Lamictal (Lamotrigine)
      • Seroquel (Quetiapine)
      • Lithium
      • Depakote
      • Olanzapine (Zyprexa)
      • Risperidone (Risperdal)
      • Carbamazepine (Tegretol)
      • Lumateperone (Caplyta)
      • Cariprazine (Vraylar)
      • Brexpiprazole (Rexulti)
      • Lurasidone (Latuda)
      • Olanzapine/Samidorphan (Lybalvi)
  • Autism
    • Autism Treatment
    • ASD Medications
    • Autism Spectrum Rating Scale
    • SRS-2
  • Breathing
    • Journaling Benefits
  • Blog
  • CBT
    • CBTWorkbook
    • Cognitive Distortions
    • CBT Worksheets
  • Insurance
  • Narcissistic Abuse
    • Pathology of Narcissism
    • Covert Narcissistic traits
    • Brain Venn Diagram
    • Narcissist Red Flag Checklist
    • Partner Narcissistic Traits
    • Narcissist - short assessment
    • 1 ) Narcissistic Relationship Assessment
    • 2) Narcissistic Relationship Assessment
    • Trauma Education
    • Grounding Techniques
    • Breathing Technique
    • Trauma Worksheets
    • Trauma Assessments
    • PCL 5 Trauma Assessment
    • ACE Childhood Trauma
    • Dissociative Experiences Scale
    • Super Traits
    • Cognitive dissonance Checklist
    • Narcissistic Personality Inventory, NPI
    • Hypersensitive Narcissism Scale (HSNS)
    • Therapy for Narcissists
    • Therapist checklist
  • Contact

Xelstrym

Xelstrym

Xelstrym (dextroamphetamine transdermal system): Overview

​
Xelstrym is a transdermal patch containing dextroamphetamine, approved by the FDA in 2022 for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals aged 6 years and older. It offers a non-oral, long-acting delivery system for stimulant treatment, making it a unique option for patients who may have difficulty swallowing pills or who prefer an alternative dosing method
Mechanism of Action
Dextroamphetamine is a central nervous system (CNS) stimulant. It works by increasing the levels of dopamine and norepinephrine in the brain through the following mechanisms:
  1. Blocking Reuptake: Prevents the reabsorption of dopamine and norepinephrine into presynaptic neurons, enhancing their availability in the synaptic cleft.
  2. Stimulating Release: Promotes the release of these neurotransmitters from presynaptic neurons.
  3. Inhibition of Monoamine Oxidase (MAO): Reduces the breakdown of dopamine and norepinephrine.
This leads to improved attention, focus, and impulse control.

​Clinical Benefits
  1. Effective ADHD Symptom Management:
    • Reduces hyperactivity, impulsivity, and inattention.
  2. Non-Oral Administration:
    • Ideal for patients with swallowing difficulties or who prefer non-oral treatment options.
    • Provides a controlled, consistent delivery of medication throughout the day.
  3. Long-Lasting Effects:
    • Offers therapeutic effects for up to 9 hours.
  4. Flexibility:
    • Can be removed earlier if shorter duration of effect is desired.

instructions-for-use.pdf
File Size: 481 kb
File Type: pdf
Download File

Your browser does not support viewing this document. Click here to download the document.

Dosage
Xelstrym is available in several strengths, corresponding to different patch sizes, delivering 4.5 mg, 9 mg, 13.5 mg, or 18 mg of dextroamphetamine per 9-hour wear period.
  1. Starting Dose:
    • Begin with the 4.5 mg/9 hours patch, applied once daily in the morning.
  2. Titration:
    • Adjust dose weekly based on clinical response and tolerability.
    • Maximum dose: 18 mg/9 hours patch per day.
  3. Administration Notes:
    • Apply to clean, dry, intact skin on the hip, upper arm, or upper back.
    • Rotate application sites daily.
    • Do not wear the patch for more than 9 hours.

Prevalence of Side EffectsXelstrym shares a side effect profile with other stimulant medications but may have unique considerations due to its transdermal delivery system.
  1. Common Side Effects (5-20%):
    • Decreased appetite.
    • Insomnia.
    • Irritability or mood swings.
    • Headache.
    • Nausea.
  2. Application Site Reactions (up to 10%):
    • Skin irritation, redness, or rash at the patch site.
    • Rotate application sites to minimize irritation.
  3. Less Common Side Effects (1-5%):
    • Increased heart rate or blood pressure.
    • Dry mouth.
    • Dizziness.
  4. Rare but Serious Side Effects (<1%):
    • Psychiatric symptoms: Agitation, hallucinations, or mania.
    • Cardiovascular events: Risk of stroke, heart attack, or sudden death in patients with structural cardiac abnormalities.
  5. Abuse Potential:
    • As a Schedule II controlled substance, Xelstrym carries a risk of abuse and dependence.

EfficacyClinical studies have shown that Xelstrym:
  • Significantly reduces ADHD symptoms compared to placebo.
  • Provides sustained symptom control throughout the day, with a convenient once-daily application.

Summary
​Xelstrym offers a novel, transdermal approach to ADHD treatment with consistent and long-lasting efficacy. Its non-oral delivery system and adjustable wear time make it an excellent option for patients seeking flexibility and convenience. Monitoring for side effects, especially skin reactions and potential abuse, is essential.
  • Home
  • Credentials
    • Published Articles
  • ADHD
    • Adult ADHD Self-Report Scale
    • ADHD Comprehensive Assessment
    • ADHD Management
    • ADHD Atypical Symptoms
    • ADHD Medications >
      • Adderall
      • Vyvanse
      • Methylphenidate
      • Concerta
      • Focalin (dexmethylphenidate)
      • Guanfacine (Intuniv)
      • Atomoxetine (Strattera)
      • Clonidine (Kapvay)
      • Onyda XR
      • Wellbutrin
      • Qelbree
      • Azstarys
      • Xelstrym
    • ADHD Medication for Anxiety >
      • Sertraline
      • Wellbutrin
      • Escitalopram (Lexapro)
      • Duloxetine (Cymbalta)
      • Venlafaxine (Effexor)
      • Buspirone (Buspar)
      • Fluoxetine (Prozac)
      • Paroxetine (Paxil)
      • Propranolol (Inderal)
      • Accutane - Adverse effects
    • Pomodoro Technique
    • ADHD Neurochemical
    • ADHD Worksheets
  • Anxiety
    • Insomnia
    • Sertraline
    • Buspirone (Buspar)
    • Fluoxetine (Prozac)
    • Effexor
    • Paroxetine (Paxil)
    • Escitalopram (Lexapro)
  • AUD
    • AUD Medications >
      • Naltrexone
      • Acamprosate
      • Disulfiram (Antabuse)
      • Topamax
      • Gabapentin
    • What to expect
    • Nutrition
    • Resources
    • Overcoming Shame
    • Health and Alcohol
    • AUD Videos
  • Bipolar
    • Bipolar Disorder Treament
    • Bipolar Disorder Worksheets
    • Bipolar Disorder Medications >
      • Abilify
      • Lamictal (Lamotrigine)
      • Seroquel (Quetiapine)
      • Lithium
      • Depakote
      • Olanzapine (Zyprexa)
      • Risperidone (Risperdal)
      • Carbamazepine (Tegretol)
      • Lumateperone (Caplyta)
      • Cariprazine (Vraylar)
      • Brexpiprazole (Rexulti)
      • Lurasidone (Latuda)
      • Olanzapine/Samidorphan (Lybalvi)
  • Autism
    • Autism Treatment
    • ASD Medications
    • Autism Spectrum Rating Scale
    • SRS-2
  • Breathing
    • Journaling Benefits
  • Blog
  • CBT
    • CBTWorkbook
    • Cognitive Distortions
    • CBT Worksheets
  • Insurance
  • Narcissistic Abuse
    • Pathology of Narcissism
    • Covert Narcissistic traits
    • Brain Venn Diagram
    • Narcissist Red Flag Checklist
    • Partner Narcissistic Traits
    • Narcissist - short assessment
    • 1 ) Narcissistic Relationship Assessment
    • 2) Narcissistic Relationship Assessment
    • Trauma Education
    • Grounding Techniques
    • Breathing Technique
    • Trauma Worksheets
    • Trauma Assessments
    • PCL 5 Trauma Assessment
    • ACE Childhood Trauma
    • Dissociative Experiences Scale
    • Super Traits
    • Cognitive dissonance Checklist
    • Narcissistic Personality Inventory, NPI
    • Hypersensitive Narcissism Scale (HSNS)
    • Therapy for Narcissists
    • Therapist checklist
  • Contact